Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Urinary Bladder Neoplasms × durvalumab × Clear all

Phase

Status

Active not recruiting 9 Completed 6 Recruiting 4 Unknown 3 Terminated 3 Withdrawn 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1 Adenocarcinoma of Lung 1 Adenocarcinoma Of Esophagus 1

Interventions

tremelimumab 3 Cystoscopy 3 avelumab 2 Paclitaxel 2 Docetaxel 2 vinflunine 1 trebananib 1 trastuzumab duocarmazine 1 infigratinib 1 erdafitinib 1 efineptakin alfa 1 durvalumab 1 copanlisib 1 atezolizumab 1 Trastuzumab 1 Taxes 1 TAS-116 1 Specimen Handling 1 Sirolimus 1 Rosiglitazone 1 Ropivacaine 1 Rogaratinib 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Optical Imaging 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Lidocaine 1 Lapatinib 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04073160 2020-07-07

TRIO Bladder

Duke University

Phase 1 Withdrawn

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡